Develops compounds for the diagnosis of viral and non-viral induced tumour-related diseases in Innsbruck, Austria.
Diagnostic and therapeutic products relating to prostate specific antigen and oncoproteins, within a division of Bayer in Cambridge, Massachusetts
Focused on photoactivation and multi-epitopic development of foreign antibodies that activate and modulate the immune system for the treatment of ovarian tumors and multiple myeloma. Profile of company, clinic and science, with investor data and contacts at University of Alberta, Edmonton, Canada.
Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.
Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.
Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.
Develops and markets novel molecular therapeutics and diagnostics for tumor markers and a cell enrichment device. Includes related projects, publications and contacts in Holzkirchen, Germany.
Company researching and developing molecular diagnostic kits for micrometastatic tumor cells in blood. Includes corporate profile, plans and contacts in Greece and Calgary, Alberta.
Company focused on the discovery and development of anti-cancer drugs through synthetic biology of natural polyketides and rapamycin analogues. Describes technology, pipeline, and facilities near Saffron Walden, England.
Developing stem cell products and therapies for hepatic diseases, offering human hepatocytes and microsomes for pre-clinical research. Overview of services, references, related links and contacts in Pathumthani, Thailand.
Health /
Conditions_and_Diseases /
Cancer /
Centers /
Research
|